Prinomastat
Alternative Names: AG 3340; AG 3354 (hydrochloride); AG 3362 (maleate); CytaqLatest Information Update: 24 Oct 2021
At a glance
- Originator Agouron Pharmaceuticals
- Class Antineoplastics; Hydroxamic acids; Small molecules; Thiamorpholines
- Mechanism of Action Angiogenesis inhibitors; Matrix metalloproteinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Age-related macular degeneration; Breast cancer; Glioblastoma; Lung cancer; Non-small cell lung cancer; Prostate cancer
Most Recent Events
- 20 Nov 2002 Discontinued - Phase-II for Age-related macular degeneration in USA (PO)
- 20 Nov 2002 Discontinued - Phase-II for Glioblastoma in USA (PO)
- 20 Nov 2002 Discontinued - Phase-II for Non-small cell lung cancer in Australia (PO)